Preclinical toxicology from a top preclinical Contract Research Organization in Kiev, UA.
Our organization is an independent CRO operating out of the U.S. that conducts pre-clinical drug testing in top-notch, GLP certified research laboratories in Kiev, UA. Our testing facilities are sponsored by the UNAMS and Ministry of Health and provide services for for-profit development of new drug discoveries as part of their core purpose. The CRO was created to provide the top-notch, lower cost services of these research sites to new biotech companies in the United States and EU, thereby providing them with a smart option for promoting development programs rapidly and at much lower cost than other commercial Contract Research Organizations. We provide a wide range of pre-clinical trials including medicine safety, chronic and acute toxicity, pharma screening, bioavailability, bioequivalence, and extensive in vitro and in vivo screening for anticancer activity.
Our pre-clinical CRO is able to price pre-clinical services far below other Contract Research Organizations because we have a very low overhead in the United States and perform all studies in Kiev, UA where labor and lab costs are much lower. Our staff in the U.S. is comprised of only of the company principals who work directly with clients; we have no promotion expenses other than our web site, and no central offices, administrative staff or other overhead to inflate costs. We have much lower study conduct prices in Ukraine due to much lower labor rates and are able to offer our best pricing for long-term and more intricate pre-clinical tests where labor is the most significant part of the overall cost. Because we use the same stable international suppliers for animal models, reagents and lab supplies as other Contract Research Organizations, we have no cost advantage on these materials and so less overall cost savings for very short-term preclinical trials. However, regardless of your trial protocol and duration, our goal is to provide our customers the best possible value for their investment.